Back to results
US 9,107,864 B2Granted
Tissue targeted antigenic activation of the immune response to treat cancers
AssigneeQu Biologics Inc.
InventorHarold David Gunn
Life of this patent
Estimating the term…
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Claims28
A method for treating a human patient having a melanoma situated in the skin or skin tissue, the method comprising:
- administering to the patient an effective amount of a medicament to treat the melanoma, the medicament comprising whole killed cells of only one microbial pathogen, wherein the microbial pathogen is Staphylococcus aureus,
- wherein the whole killed cells are whole cells wherein the whole killed cells are present in an amount effective to elicit an immune reaction effective to treat the melanoma.
A method for selecting an antigenic composition and treating a human patient, comprising:
- diagnosing the patient as having a melanoma situated in the skin or skin tissue;
- selecting an antigenic composition comprising whole killed cells of only one microbial pathogen, wherein the microbial pathogen is Staphylococcus aureus;
- and,
- administering the antigenic composition to the patient to elicit an immune reaction to treat the melanoma,
- wherein the whole killed cells are whole cells wherein the whole killed cells are present in an amount effective to elicit an immune reaction effective to treat the melanoma.
2 more elements
Dependencies are inferred from the claim text.